Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Artificial Intelligence and Cancer Staging in Upper Gastrointestinal Malignancies
A clinical trial investigating artificial intelligence–assisted cancer staging in upper gastrointestinal malignancies has completed. The stu…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Neoadjuvant Immunotherapy for Resectable Gastric Cancer [Phase 2]
Phase 2 neoadjuvant immunotherapy trial for resectable gastric cancer has completed, sponsored by Qilu Hospital of Shandong University.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 trial evaluating NC410 in combination with pembrolizumab for advanced unresectable or metastatic solid tumors across mul…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer [NA]
A clinical trial evaluating the value of three DWI imaging sequences for staging gastric cancer is currently recruiting at Yunnan Cancer Hos…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: BI-1607 in Combination with Trastuzumab in Subjects with HER2-positive Advanced Solid Tumors [Phase 1, Phase 2]
BI-1607 in combination with Trastuzumab for HER2-positive advanced solid tumors (Phase 1/2) has been terminated. The study included HER2-pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric Cancer [NA]
A clinical trial evaluating a multimodal prehabilitation program to improve outcomes for frail elderly patients with gastric cancer; current…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma [Phase 1, Phase 2]
The clinical trial of CYNK-101 in combination with trastuzumab and pembrolizumab for HER2-positive gastric or gastroesophageal junction canc…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 trial SHR-A1904 vs investigator's choice therapy is recruiting for Claudin18.2-positive second-line advanced or metastatic gastric o…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors [Phase 2]
Phase 2 trial of Utidelone as monotherapy for advanced solid tumors, currently not recruiting.
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
A clinical trial evaluating first-line and neoadjuvant immunotherapy for gastric cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Comprehensive Outcomes for After Cancer Health [NA]
A clinical trial update from Pack Health indicates the study on comprehensive outcomes for after-cancer health is currently recruiting, cove…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating TEW-7197 with paclitaxel for metastatic gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab [Phase 1, Phase 2]
Zanidatamab (ZW25) in combination with chemotherapy, with or without tislelizumab, is being evaluated in Phase 1/2 trials for breast cancer,…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: A Study on Early Removal of Urinary Catheter After Gastric Cancer Surgery Applying ERAS Protocols [NA]
The document reports the completion of a study evaluating early removal of urinary catheters after gastric cancer surgery under ERAS protoco…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors [Phase 1]
An update on a Phase 1 trial of ACE1702 for advanced or metastatic HER2-expressing solid tumors; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer [Phase 2]
A Phase 2 study evaluating tusamitamab ravtansine in combination with ramucirumab for pretreated gastric or gastroesophageal cancer has been…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Trajectory of Body Composition Identifies LAGC with Cachexia Following NACT
A completed clinical trial update reports that body composition trajectory may identify locally advanced gastric cancer patients who develop…
-
CLINICAL_TRIALS withdrawal · 2024-12-03Clinical Trial Update: Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer [Phase 3]
A Phase 3 trial comparing adjuvant S-1 plus oxaliplatin to S-1 alone in locally advanced gastric cancer was terminated.
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer [Phase 2]
Phase 2 clinical trial investigating a triplet therapy of trifluridine/tipiracil (TAS-102), bevacizumab, and camrelizumab for third-line or …
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma [NA]
Clinical trial update for IMAB362 (zolbetuximab) in Japanese patients with locally advanced or metastatic gastric or GEJ adenocarcinoma; the…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)
This entry documents a clinical trial for the Vocorder device validation (Vocorder Clinical Validation-VCV) to continuously monitor individu…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study
A completed retrospective study assessed whether Helicobacter pylori eradication after subtotal gastrectomy influences survival in gastric c…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis [Phase 2]
A Phase 2 study evaluating BO-112 in combination with pembrolizumab for colorectal and gastric/GEJ cancers with liver metastasis has been te…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Fibrin Glue After ESD for High Risk Patients of Bleeding [NA]
The clinical trial update reports the completion of a study evaluating the use of fibrin glue after endoscopic submucosal dissection in high…
-
CLINICAL_TRIALS other · 2024-11-29Clinical Trial Update: Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer
Clinical trial update shows a study evaluating pepsinogen II and Helicobacter pylori testing in gastric cancer, sponsored by Seoul National …